These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7025474)

  • 21. Predicting more accurately the overall glucose response to a lunch meal by using the postprandial glucose peak.
    Chapelot D; Marmonier C; Valensi P
    Metabolism; 2007 Jan; 56(1):37-43. PubMed ID: 17161224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
    Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Organization of a parenteral nutrition program for post-stress metabolism with reference to existing metabolic changes].
    Schmitz JE; Seeling W; Altemeyer KH; Grünert A; Ahnefeld FW
    Beitr Infusionther Klin Ernahr; 1986; 13():23-34. PubMed ID: 3098223
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects.
    Salinari S; Bertuzzi A; Gandolfi A; Greco AV; Scarfone A; Manco M; Mingrone G
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1051-8. PubMed ID: 16787959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls.
    Jensen CB; Storgaard H; Holst JJ; Dela F; Madsbad S; Vaag A
    Metabolism; 2005 Oct; 54(10):1398-406. PubMed ID: 16154442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and hormonal effects of xylitol in man.
    Rubenstein AH; Spitz I; Bersohn I
    Z Ernahrungswiss Suppl; 1971; 11():44-8. PubMed ID: 5290594
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin and metabolic substrates during human sepsis.
    Finney SJ
    Crit Care; 2004 Aug; 8(4):227-8. PubMed ID: 15312202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of the lipolytic action of adrenaline and noradrenaline in normal subjects].
    Balestreri R; Pompei A; Jacopino GE
    Arch Maragliano Patol Clin; 1967; 23(2):173-9. PubMed ID: 5632819
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenoceptors mediating the cardiovascular and metabolic effects of alpha-methylnoradrenaline in humans.
    Schäfers RF; Nürnberger J; Herrmann B; Wenzel RR; Philipp T; Michel MC
    J Pharmacol Exp Ther; 1999 May; 289(2):918-25. PubMed ID: 10215671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of maternal dietary fatty acid composition on glucose and lipid metabolism in male rat offspring aged 105 d.
    Ibrahim A; ; Basak S; Ehtesham NZ
    Br J Nutr; 2009 Jul; 102(2):233-41. PubMed ID: 19166630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose, insulin, and free fatty acids in uremia.
    Roth DA; Meade RC; Barboriak JJ
    Diabetes; 1973 Feb; 22(2):111-4. PubMed ID: 4687644
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of previous treatment with noradrenaline on the course of metabolic changes in endotoxic fever].
    Solc J; Vondrichová I; Klik J
    Cas Lek Cesk; 1969 Jun; 108(26):784-7. PubMed ID: 5786029
    [No Abstract]   [Full Text] [Related]  

  • 35. Norepinephrine-induced rise in circulating blood platelets and free fatty acids in arterial and venous blood of patients with ischaemic heart disease and controls.
    Bucher HW; Stucki P
    Helv Med Acta; 1969 Mar; 34(6):503-9. PubMed ID: 5779216
    [No Abstract]   [Full Text] [Related]  

  • 36. [The activity of free fatty acids in the serum of children under noradrenaline].
    Becker A; Spahn U; Plenert W
    Z Kinderheilkd; 1966; 96(4):372-9. PubMed ID: 5984894
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic and endocrine alterations induced by endotoxin and sepsis at the cellular level.
    Spitzer JA; Leach GJ; Reeves JA
    Prog Clin Biol Res; 1981; 62():123-30. PubMed ID: 7025009
    [No Abstract]   [Full Text] [Related]  

  • 38. Further studies on the effect of octanoate on glucose metabolism in dogs.
    Sanbar SS; Evans JR; Lin B; Hetenyi G
    Can J Physiol Pharmacol; 1967 Jan; 45(1):29-38. PubMed ID: 6030400
    [No Abstract]   [Full Text] [Related]  

  • 39. Pitfalls in interpretation of oral glucose tolerance tests in the newborn.
    Pildes RS; Hart RJ; Warrner R; Cornblath M
    Pediatrics; 1969 Jan; 43(1):92-4. PubMed ID: 5764073
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of secretin on blood sugar and nonesterified fatty acids during fasting and following parenteral glucose adminstration].
    Kaess H; Zickermann A
    Verh Dtsch Ges Inn Med; 1967; 73():281-3. PubMed ID: 5591763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.